These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 8549369)

  • 1. Clinical assessment of indices for the prognosis of urinary tract infection in elderly patients receiving prophylaxis with norfloxacin.
    Toba K; Nagano K; Liang J; Ouchi Y; Orimo H
    Drugs; 1995; 49 Suppl 2():382-3. PubMed ID: 8549369
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of norfloxacin for prevention of symptomatic urinary tract infection in chronically catheterized patients.
    Rutschmann OT; Zwahlen A
    Eur J Clin Microbiol Infect Dis; 1995 May; 14(5):441-4. PubMed ID: 7556234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient compliance and efficacy of low-dose, long-term prophylaxis in patients with recurrent urinary tract infection.
    Westenfelder M; Vahlensieck W; Reinhartz U
    Chemioterapia; 1987 Jun; 6(2 Suppl):530-2. PubMed ID: 3509492
    [No Abstract]   [Full Text] [Related]  

  • 4. Single-dose ciprofloxacin versus 3 days of norfloxacin in uncomplicated urinary tract infections in women.
    Auquer F; Cordón F; Gorina E; Caballero JC; Adalid C; Batlle J;
    Clin Microbiol Infect; 2002 Jan; 8(1):50-4. PubMed ID: 11906502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Open randomised comparison of ofloxacin and norfloxacin in the treatment of complicated urinary tract infections.
    Rugendorff EW
    Drugs; 1987; 34 Suppl 1():91-4. PubMed ID: 3481333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative trial of norfloxacin and macrocrystalline nitrofurantoin (Macrodantin) in the prophylaxis of recurrent urinary tract infection in women.
    Brumfitt W; Hamilton-Miller JM; Smith GW; al-Wali W
    Q J Med; 1991 Oct; 81(294):811-20. PubMed ID: 1801054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and tolerability of brodimoprim od versus norfloxacin bid in the treatment of bacterial urinary tract infections.
    Scaglione F; Demartini G; Cocuzza C; Raschi S; Cogo R
    Int J Clin Pharmacol Res; 1995; 15(3):121-5. PubMed ID: 8847153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is antibiotic prophylaxis required for flexible cystoscopy? A truncated randomized double-blind controlled trial.
    Wilson L; Ryan J; Thelning C; Masters J; Tuckey J
    J Endourol; 2005 Oct; 19(8):1006-8. PubMed ID: 16253070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of norfloxacin 800 mg once-daily versus norfloxacin 400 mg twice-daily in the treatment of uncomplicated urinary tract infections in women: a double-blind, randomized clinical trial.
    Pimentel FL; Dolgner A; Guimarães J; Quintas M; Mário-Reis J
    J Chemother; 1998 Apr; 10(2):122-7. PubMed ID: 9603637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term prophylaxis with norfloxacin versus nitrofurantoin in women with recurrent urinary tract infection.
    Raz R; Boger S
    Antimicrob Agents Chemother; 1991 Jun; 35(6):1241-2. PubMed ID: 1929272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Norfloxacin--its current role in pharmacotherapy].
    Stojiljković MP; Jovanović D
    Vojnosanit Pregl; 1998; 55(3):291-304. PubMed ID: 9720445
    [No Abstract]   [Full Text] [Related]  

  • 12. In vivo activity of ciprofloxacin, ofloxacin, norfloxacin and pipemidic acid against Escherichia coli infections in mice.
    Obana Y; Nishino T
    Drugs Exp Clin Res; 1989; 15(2):53-8. PubMed ID: 2661182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose norfloxacin versus placebo for long-term prophylaxis of recurrent uncomplicated urinary tract infection.
    Rugendorff E; Haralambie E
    Chemioterapia; 1987 Jun; 6(2 Suppl):533-5. PubMed ID: 3334616
    [No Abstract]   [Full Text] [Related]  

  • 14. [Analysis of urinary infection in the 1st month after kidney transplantation. Value of short prophylaxis with norfloxacin].
    Jasovich A; Vázquez L; Cassetti I; Barclay C; Cavalli NH; López Blanco O; Stamboulian D
    Enferm Infecc Microbiol Clin; 1990 Oct; 8(8):496-500. PubMed ID: 2095261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Norfloxacin-induced hallucination--an unusual CNS toxicity of 4-fluoroquinolones.
    Kundu AK
    J Assoc Physicians India; 2000 Sep; 48(9):944. PubMed ID: 11198813
    [No Abstract]   [Full Text] [Related]  

  • 16. Infections caused by Escherichia coli resistant to norfloxacin in hospitalized cirrhotic patients.
    Ortiz J; Vila MC; Soriano G; Miñana J; Gana J; Mirelis B; Novella MT; Coll S; Sábat M; Andreu M; Prats G; Solá R; Guarner C
    Hepatology; 1999 Apr; 29(4):1064-9. PubMed ID: 10094947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of norfloxacine prophylaxis in late recurrent urinary tract infection after renal transplantation.
    Hernandez Poblete G; Morales JM; Prieto C; Andrés A; Ortuño T; Rodicio JL
    Nephron; 1990; 54(2):193-4. PubMed ID: 2314533
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of uncomplicated recurrent cystitis in women: lomefloxacin versus norfloxacin].
    Guibert J; Herman H; Capron MH
    Contracept Fertil Sex; 1997 Jan; 25(1):79-84. PubMed ID: 9064058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of self-start therapy in women with recurrent urinary tract infections.
    Schaeffer AJ; Stuppy BA
    J Urol; 1999 Jan; 161(1):207-11. PubMed ID: 10037399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective, randomized, placebo-controlled trial of norfloxacin for the prophylaxis of recurrent urinary tract infection in women.
    Nicolle LE; Harding GK; Thompson M; Kennedy J; Urias B; Ronald AR
    Antimicrob Agents Chemother; 1989 Jul; 33(7):1032-5. PubMed ID: 2675752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.